Mirae Asset Global ETFs Holdings’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Mirae Asset Global ETFs Holdings's NVAX Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings increased its Novavax (NVAX) stake by 7.5% in Q2 2026, buying an estimated $59.3K and bringing the position to 94,461 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #1697.
Mirae Asset Global ETFs Holdings first reported a position in NVAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.17M in Q3 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 94,461 shares of Novavax worth $888K as of Q2 2026.
- Mirae Asset Global ETFs Holdings bought 6,619 Novavax shares in Q2 2026, an estimated $59.3K.
- Novavax made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1697 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Novavax in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's Novavax position peaked at $1.17M in Q3 2024.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.